ADO expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.33350000328403E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.26449999979539E-07 |
Normal-vs-Stage2 |
1.350210E-04 |
Normal-vs-Stage3 |
3.76069999585837E-08 |
Normal-vs-Stage4 |
3.98759999464815E-08 |
Stage1-vs-Stage2 |
1.907960E-01 |
Stage1-vs-Stage3 |
7.135000E-03 |
Stage1-vs-Stage4 |
2.091600E-02 |
Stage2-vs-Stage3 |
6.958000E-01 |
Stage2-vs-Stage4 |
9.580800E-01 |
Stage3-vs-Stage4 |
6.454400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.73680003501664E-09 |
Normal-vs-AfricanAmerican |
5.75429999999377E-05 |
Normal-vs-Asian |
1.541950E-01 |
Caucasian-vs-AfricanAmerican |
6.948400E-01 |
Caucasian-vs-Asian |
5.281400E-01 |
AfricanAmerican-vs-Asian |
5.873200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.68439997902692E-09 |
Normal-vs-Female |
8.07119999945982E-07 |
Male-vs-Female |
4.513900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.138200E-03 |
Normal-vs-Age(41-60Yrs) |
1.7349000003275E-07 |
Normal-vs-Age(61-80Yrs) |
4.17190000323586E-08 |
Normal-vs-Age(81-100Yrs) |
1.395720E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.726000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.675600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.395600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.685600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.917600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.570600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.734000E-02 |
Normal-vs-Grade 2 |
5.585800E-04 |
Normal-vs-Grade 3 |
3.22075699443758E-12 |
Normal-vs-Grade 4 |
1.75520042944299E-10 |
Grade 1-vs-Grade 2 |
4.485400E-01 |
Grade 1-vs-Grade 3 |
3.318000E-02 |
Grade 1-vs-Grade 4 |
8.423400E-03 |
Grade 2-vs-Grade 3 |
3.199700E-04 |
Grade 2-vs-Grade 4 |
1.351040E-04 |
Grade 3-vs-Grade 4 |
2.933400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.57239999995807E-06 |
Normal-vs-ccB subtype |
1.45839999965425E-07 |
ccA subtype-vs-ccB subtype |
2.546000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.51680000027544E-07 |
Normal-vs-N1 |
6.718000E-03 |
N0-vs-N1 |
8.848600E-01 |
|
|